Nordic Nanovector ASA - Notice of Extraordinary General Meeting on 1 December 2022
Oslo, Norway, 10 November 2022 Reference is made to the stock exchange announcement by Nordic Nanovector ASA ("Nordic Nanovector" or the "Company") on 9 November 2022 announcing that the Company has entered into a merger agreement with all shareholders of APIM Therapeutics AS to combine the companies in an all-stock transaction. Completion of the transaction is dependent on the approval by the General Meeting of the Company. Nordic Nanovector hereby calls for an Extraordinary General Meeting in the Company to be held on 1 December 2022, at 10:00 hours CET at Advokatfirmaet Selmer,